Issue 9/2013
Content (12 Articles)
Proteomic biomarkers in lung cancer
M. D. Pastor, A. Nogal, S. Molina-Pinelo, A. Carnero, L. Paz-Ares
Research opportunities in intraoperative radiation therapy: the next decade 2013–2023
F. A. Calvo, C. V. Sole, M. E. González, E. D. Tangco, J. López-Tarjuelo, I. Koubychine, J. A. Santos, J. Pascau, R. Herranz, C. Ferrer
Clinical and prognostic usefulness of serum proteomic profile in hepatic colorectal metastases: a pilot prospective study
J. Martí, J. Fuster, J. M. Estanyol, F. Fernández, R. Deulofeu, J. Ferrer, A. Pelegrina, A. Reyes, C. Fondevila, J. C. García-Valdecasas
Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)
J. P. Maroto, X. G. del Muro, B. Mellado, J. L. Perez-Gracia, R. Andrés, J. Cruz, E. Gallardo, M. Domenech, J. Á. Arranz, J. A. Meana
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer
A. Carrato, A. Gómez, P. Escudero, M. Chaves, F. Rivera, E. Marcuello, E. González, C. Grávalos, M. Constenla, J. Luis Manzano, F. Losa, J. Maurel, R. Dueñas, B. Massuti, J. Gallego, J. Aparicio, A. Antón, E. Aranda
Carnosol, radiation and melanoma: a translational possibility
M. Alcaraz, D. G. Achel, A. Olivares, E. Olmos, M. Alcaraz-Saura, J. Castillo
Beam angle selection for intensity-modulated radiotherapy (IMRT) treatment of unresectable pancreatic cancer: are noncoplanar beam angles necessary?
D. S. Chang, G. K. Bartlett, I. J. Das, H. R. Cardenes
Management of malignant insulinoma
J. C. Ferrer-García, V. Iranzo González-Cruz, S. Navas-DeSolís, M. Civera-Andrés, C. Morillas-Ariño, Á. Merchante-Alfaro, C. Caballero-Díaz, C. Sánchez-Juan, C. Camps Herrero
Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases
Y.-X. Chen, Z.-C. Zeng, J. Fan, Z.-Y. Tang, J. Zhou, M.-S. Zeng, J.-Y. Zhang, J. Sun
Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression
P. Liu, H. Liang, Q. Xia, P. Li, H. Kong, P. Lei, S. Wang, Z. Tu
Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung
B. Jeremić, B. Miličić, S. Milisavljević
Clinical target volume definition for glioblastoma radiotherapy planning: magnetic resonance imaging and computed tomography
A. Fiorentino, R. Caivano, P. Pedicini, V. Fusco